‘An arm and a leg’: New caps on Medicare drug spending

Can’t see the audio player? Click here to listen.

Click here for a transcript of the episode.

On a Sunday afternoon in August, health services researcher Stacy Dusetzina sat alone in her office at Vanderbilt University, C-Span watches and cries.

The US Senate was voting on the Inflation Reduction Act, which is designed to, among other things, ensure that people on Medicare pay less for expensive drugs.

It’s a big deal. Many seniors pay $10,000 or more a year for drugs or do without life-saving treatment; Once the new law goes into effect, it sets an out-of-pocket limit of $2,000 a year.

Dusetzina and her colleagues have spent years making the case for this change, documenting the ways in which current policies are driving people into idleness.

The pharmaceutical industry has fought this change tooth and nail β€” for decades. Julie Rovner, KHN’s chief Washington correspondent, takes listeners on a journey to the late 1980s, when Congress learned the cost of messing with Big Pharma.

“An Arm and a Leg” is a co-production of KHN and Public Road Productions.

To stay in touch with “An Arm and a Leg”, subscribe to the newsletter. You can also follow the show on Facebook and Twitter. And if you have a story to tell about the health care system, producers would love to hear from you.

To listen to all KHN podcasts, click here.

And subscribe to “An Arm and a Leg” on Spotify, Apple Podcasts, Stitcher, Pocket Casts, or wherever you listen to podcasts.

We encourage companies to republish our content free of charge. Here’s what we ask:

You must credit us as the original publisher with a hyperlink to our khn.org site. If possible, please include the original author(s) and “Kaiser Health News” in the byline. Save the hyperlink in the story.

It’s important to note, not everything on khn.org is available for republishing. If a story is labeled “All Rights Reserved,” we may not allow that item to be republished.

Have questions? Let us know at [email protected]

Leave a Reply

Your email address will not be published.